Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

NorwayBack to Norway

Clinical trials in Levanger – page 2

14 clinical trials in Levanger, Norway. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Levanger at a glance
14
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

14 trials in Levanger

Open in trial search

Non-small cell lung cancer+1

Not recruiting

Study on the Effectiveness and Safety of UV1 Vaccine with or without Sargramostim for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

InvestigationalNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Alrefimotide
  • Sponsor:Vestre Viken HF

Small cell lung cancer

Not recruiting

Study on Atezolizumab with Chemoradiotherapy for Patients with Limited Disease Small-Cell Lung Cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Norwegian University Of Science And Technolology

Other cities in Norway

The busiest research cities in the country

All 54 cities in Norway

Clinical research in Levanger

What the registry says about research in the country

01 Oncology Research

Groundbreaking studies focusing on precision cancer medicine for rare and hard-to-treat cancers, including innovative approaches to drug repurposing and targeted therapies.

  • Rare Cancer Treatment
  • Advanced Malignancies
  • Targeted Anti-cancer Drugs

Research aims to improve treatment outcomes through personalized therapeutic approaches.

02 Lung Cancer Studies

Comprehensive research into small-cell lung cancer and non-small cell lung cancer, evaluating innovative combination therapies including immunotherapy and radiotherapy.

  • Extensive Stage SCLC
  • Limited Disease SCLC
  • Advanced NSCLC

Studies focus on improving survival rates through combined treatment modalities.

03 Autoimmune Conditions

Clinical investigations of treatments for Crohn's Disease and Immune Thrombocytopenia, testing new therapeutic approaches and maintenance strategies.

  • Inflammatory Bowel Disease
  • Blood Disorders
  • Long-term Treatment Efficacy

Evaluating novel therapies for chronic autoimmune conditions with focus on long-term management.

Back to NorwayAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.